-+ 0.00%
-+ 0.00%
-+ 0.00%

*PTC Therapeutics, Inc.: Agreed to Acquire From Sangamo Assets Primarily Related to ST-920, an AAV Gene Therapy Product Candidate for Fabry Disease >PTCT

Dow Jones·08/28/2026 21:42:00

Please log in to view news